CABLIVI
CABLIVI
Discontinued
DIN Number
02496194
Drug Class
Human
Market Date
Sep 4, 2020
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02496194
AIG Number0162033001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
B01AX07 CAPLACIZUMAB
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
CAPLACIZUMABActive
Strength: 11 MG / VIAL
Monograph: CAPLACIZUMAB